Celldex (CLDX) Prices 13.378M Share Common Offering at $9.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
After-Hours Stock Movers 06/15: (WW) (MBIO) (VRAY) Higher; (CLDX) (AVEO) (AAXN) Lower (more...)
June 15, 2020 5:41 PM EDTToday's After-Hours Stock Movers
Weight Watchers International, Inc. (NASDAQ: WW) 12.3% HIGHER; had 4.9 million subscribers as of June 6, 2020, up 7%; Amends Revolving Credit Facility
Celldex Therapeutics, Inc. (NASDAQ: CLDX) 5.7% LOWER; announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Celldex expects to grant the underwriters a 30day... More
Celldex (CLDX) Announces Proposed Common Share Offering
June 15, 2020 4:04 PM EDTCelldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Celldex expects to grant the underwriters a 30day option to purchase up to an... More
Celldex Therapeutics (CLDX) PT Raised to $12 at Cantor Fitzgerald After Positive CDX-0159 Data
June 12, 2020 6:33 AM EDTCantor Fitzgerald analyst Kristen Kluska raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $12.00 (from $8.00) after including the CDX-0159 data that were presented on 6/6 and shifting to a DCF based model. Shares rose 193% over the last two days, in part, due to insider buying... More
